Bellevue Life Sciences Acquisition Corp.
$3.01
-3.72 (-55.27%)
BLAC Price Chart
| Basic | |
|---|---|
| Market Cap | $24.85M |
| Price | $3.01 |
| 52 Week Range | 5.61-13.4 |
| Beta | -0.01 |
| Margins | |
| Gross Profit Margin | |
| Operating Profit Margin | |
| Net Profit Margin | |
| Valuation (TTM) | |
| P/E Ratio | |
| Price to Sales Ratio | |
| Price to Book Ratio | |
| PEG Ratio | |
Industry
Shell Companies
Sector
Financial Services
IPO Date
2023-03-21T00:00:00.000Z
Description
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Phone
425 635 7700
Address
10900 NE 4th Street, Bellevue, WA, 98004, US
CIK
0001840425